TABLE 418-4 -PREFERRED ANTIRETROVIRAL COMBINATION REGIMENS FOR INITIAL THERAPY IN PATIENTS WITH ESTABLISHED HIV INFECTION
| Preferred regimens include one drug or combination from the left column plus one of the nucleoside reverse transcriptase inhibitor combinations in the right column | ||
| NON-NRTI | plus | NRTI COMBINATIONS |
| Indinavir or | Zidovudine plus didanosine or | |
| Nelfinavir or | Stavudine plus didanosine or | |
| Ritonavir or | Zidovudine plus zalcitabine or | |
| Saquinavir-soft gel or | Zidovudine plus lamivudine or | |
| Ritonavir plus saquinavir (soft or hard gel) or | Stavudine plus lamivudine | |
| Efavirenz | ||
Note: Listings in each column are in random order, not priority order.
* Based on recommendations of the panel convened by the Department of Health and Human Services and the Henry J. Kaiser Family Foundation.